Journal Of Cardiovascular Medicine

Journal Of Cardiovascular Medicine

心血管医学杂志

  • 3区 中科院分区
  • Q2 JCR分区

期刊简介

《Journal Of Cardiovascular Medicine》是由Lippincott Williams and Wilkins Ltd.出版社于2006年创办的英文国际期刊(ISSN: 1558-2027,E-ISSN: 1558-2035),该期刊长期致力于心脏和心血管系统领域的创新研究,主要研究方向为医学-心血管系统。作为SCIE收录期刊(JCR分区 Q2,中科院 3区),本刊采用OA未开放获取模式(OA占比0.0447...%),以发表心脏和心血管系统领域等方向的原创性研究为核心(研究类文章占比86.26%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在131篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Journal Of Cardiovascular Medicine审稿周期约为 较慢,6-12周 。该刊近年未被列入国际预警名单,年发文量约131篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 131 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q2 77 / 220

65.2%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q2 100 / 220

54.77%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:3.9 SJR:0.544 SNIP:0.491
学科类别 分区 排名 百分位
大类:Medicine 小类:Cardiology and Cardiovascular Medicine Q2 158 / 387

59%

期刊发文

  • Validation of a predictive model for coronary artery disease in patients with diabetes

    Author: Xu, Junhong; Zhao, Qiongrui; Li, Juan; Yuan, Youhua; Cao, Xingguo; Zhang, Xueyan; Fang, Jia; Yan, Wenjuan; Wang, Baoya; Li, Yi; Chu, Yingjie

    Journal: JOURNAL OF CARDIOVASCULAR MEDICINE. 2023; Vol. 24, Issue 1, pp. 36-43. DOI: 10.2459/JCM.0000000000001387

  • Effectiveness and safety of angiotensin receptor-neprilysin inhibitor and sodium-glucose cotransporter-2 inhibitors for patients with heart failure with reduced ejection fraction: a meta-analysis

    Author: Huang, Yun; Fang, Chongbo; Zhang, YuYu; Ma, Lili; Zhou, Hua; Ye, Honghua

    Journal: JOURNAL OF CARDIOVASCULAR MEDICINE. 2023; Vol. 24, Issue 2, pp. 123-131. DOI: 10.2459/JCM.0000000000001426

  • Relationship between epicardial adipose tissue attenuation and coronary artery disease in type 2 diabetes mellitus patients

    Author: Liu, Zihou; Neuber, Sebastian; Klose, Kristin; Jiang, Meng; Kelle, Sebastian; Zhou, Ningbo; Wang, Shunjun; Stamm, Christof; Luo, Fanyan

    Journal: JOURNAL OF CARDIOVASCULAR MEDICINE. 2023; Vol. 24, Issue 4, pp. 244-252. DOI: 10.2459/JCM.0000000000001454

  • SGLT2i alleviates epicardial adipose tissue inflammation by modulating ketone body-glyceraldehyde-3-phosphate dehydrogenase malonylation pathway

    Author: Li, Lina; Hua, Cuncun; Liu, Xiaoyan; Wang, Yidan; Zhao, Lei; Zhang, Yeping; Wang, Li; Su, Pixiong; Yang, Min-Fu; Xie, Boqia

    Journal: JOURNAL OF CARDIOVASCULAR MEDICINE. 2023; Vol. 24, Issue 4, pp. 232-243. DOI: 10.2459/JCM.0000000000001453

  • The functional effect of atorvastatin dose-dependent via inflammation factors on acute ST segment elevation myocardial infarction after emergency percutaneous coronary intervention.

    Author: Liu Q1, Wang Y1, Cheng X2.

    Journal: J Cardiovasc Med (Hagerstown). 2019 Apr;20(4):215-219. doi: 10.2459/JCM.0000000000000711.

  • Shrinkage as a potential mechanism of recurrent clinical events in patients with a large vulnerable plaque.

    Author: Liu X1,2, Sun C1,2, Tian J1,2, Liu X1,2, Fang S1,2, Xi X1,2, Gu X2,3, Sun Y1,2, Tian J1,2, Yu B1,2.

    Journal: J Cardiovasc Med (Hagerstown). 2019 Mar 18. doi: 10.2459/JCM.0000000000000783. [Epub ahead of print]

  • Global longitudinal strain in prosthesis-patient mismatch: relation to left ventricular mass regression and outcomes.

    Author: Zhang HW1,2, Gu J1,2, Xiao ZH1,2, Li YJ3, Yang P1, Huang Y1, Lu C1, Zhang EY1, Hu J1.

    Journal: J Cardiovasc Med (Hagerstown). 2019 May 10. doi: 10.2459/JCM.0000000000000819. [Epub ahead of print]

  • Treating cardiac myxomas: a 16-year Chinese single-center study.

    Author: Lin Y, Xiao J, Chen J, Hong J, Peng H, Kang B, Wu L, Wang Z.

    Journal: J Cardiovasc Med (Hagerstown). 2016 Jan;17(1):44-53. doi: 10.2459/JCM.0000000000000114.